Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun;37(3):430-431.
doi: 10.3803/EnM.2022.303. Epub 2022 Jun 29.

Sclerostin as a Putative Myokine in Sarcopenia

Affiliations
Editorial

Sclerostin as a Putative Myokine in Sarcopenia

Hyon-Seung Yi. Endocrinol Metab (Seoul). 2022 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported.

References

    1. Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013;19:179–92. - PubMed
    1. Li X, Ominsky MS, Niu QT, Sun N, Daugherty B, D’Agostin D, et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res. 2008;23:860–9. - PubMed
    1. Modder UI, Hoey KA, Amin S, McCready LK, Achenbach SJ, Riggs BL, et al. Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res. 2011;26:373–9. - PMC - PubMed
    1. Saeki C, Tsubota A. Influencing factors and molecular pathogenesis of sarcopenia and osteosarcopenia in chronic liver disease. Life (Basel) 2021;11:899. - PMC - PubMed
    1. Nga HT, Jang IY, Kim DA, Park SJ, Lee JY, Lee S, et al. Serum GDF15 level is independent of sarcopenia in older Asian adults. Gerontology. 2021;67:525–31. - PubMed

Publication types

LinkOut - more resources